RIP2 Caspase-1 Signaling in Macrophages
RIP2 Caspase-1 Signaling in Macrophages
批准号:
8208001
负责人:
Mark Damian Wewers
金额:
$37.13万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-01-12 至 2013-12-31
关键词:
AG 126AffectAnimalsAnti-Inflammatory AgentsAnti-inflammatoryApoptosisBiologyCASP1 geneCaspaseCaspase-1Cell DeathCellsCessation of lifeComplexCytosolDataDiseaseDown-RegulationEnzyme ActivationEventHomologous GeneHost DefenseImmune responseIndividualInfectionInfectious AgentInflammationInflammatoryInflammatory ResponseInjuryInterleukin-18LaboratoriesLeadLeucineLinkLungMediatingMembraneMolecularOutcomePathogenesisPhosphorylationPhosphotransferasesPlantsPlayProcessProtein Tyrosine KinaseProteinsRIPK2 geneRegulationRoleSepsisSeptic ShockSeveritiesSignal TransductionSystemTyrphostinsUnited Statescaspase-5cytokineimprovedknockout animalmacrophagemarenostrinmortalitynovel therapeutic interventionpathogenprotein complexresponseseptictrafficking
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
Macrophage release of 17 kDa IL-1¿ is a highly regulated event that extends beyond the macrophage's
ability to transcribe and synthesize the precursor, 31 kDa proIL-1¿. This event is centered upon activation of
the enzyme caspase-1 and involves a complex protein assemblage termed the inflammasome. Inflammasome
components are homologues of an ancient innate host defense system that exists in both plants and animals.
The present proposal seeks to expand upon the clues derived from the macrophage biology of IL-1¿ and
extend these processes to the basics of the host response to sepsis. We have recent data to demonstrate that
key components of this intracellular inflammasome complex contribute significantly to the devastating
activation of the innate host response that defines septic shock. More specifically, caspase-1, the central
target of the inflammasome has been directly linked to sepsis. Not only are caspase-1 knockout animals
protected from sepsis mortality but individual components of the caspase-1 inflammasome complex (e.g.,
caspase-5, ASC and NALP1) have also been linked to sepsis outcomes. These proteins interact with each
other via caspase recruitment domains (CARDs) and structurally related pyrin domains (PYDs). Our
hypothesis is that posttranslational events centered upon these CARD and PYD domains are central to the
pathogenesis of sepsis. Inflammasome assembly not only regulates the processing and activation of
inflammatory cytokines like IL-1¿ and IL-18 but extends to the regulation of NF¿B and host cell apoptosis.
The current proposal seeks to apply these exciting breakthroughs in the biology of macrophage
function to the challenge of sepsis. We know that one of the key regulatory events in inflammasome assembly
is the triggering of CARD/CARD and PYD/PYD interactions. We have recently demonstrated that regulating
CARD-containing molecules (e.g., RIP2 and ASC) can direct the caspase-1 centered inflammatory response
either toward NF¿B or toward IL-1¿ processing. Interestingly, these events involve an early phosphorylation
event since inhibition of tyrosine kinase activity profoundly affects the inflammasome and also protects animals
from sepsis. Thus, this proposal seeks to dissect the molecular details of how these events are regulated.
The central hypothesis is that the master regulatory switch that determines the direction and severity of the pro
and anti-inflammatory responses to septic challenge are controlled in the cytosol by specific CARD/CARD and
PYD/PYD interactions. We will dissect the mechanisms that regulate the ability of caspase-1 and RIP2 to
interact, traffic to membranes and then direct host inflammation. These events initially induce NFkB activation
but subsequently, via caspase-1 catalytic activation, may finally induce apoptosis and down regulation of NF¿B
events. These studies will improve our understanding of the basic innate host responses to sepsis and in
doing so uncover novel therapeutic approaches to septic shock and other inflammatory disorders that are
regulated by this caspase-1-centric process.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulation of lung host defense by inflammasome modifiers
-
批准号:8048861
-
项目类别:
-
资助金额:$19.06万
-
财政年份:2010
-
负责人:Mark Damian Wewers
-
依托单位:
Regulation of lung host defense by inflammasome modifiers
-
批准号:8204686
-
项目类别:
-
资助金额:$22.88万
-
财政年份:2010
-
负责人:Mark Damian Wewers
-
依托单位:
RIP2 caspase-1 signaling in macrophages
-
批准号:7583471
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2009
-
负责人:Mark Damian Wewers
-
依托单位:
RIP2 caspase-1 signaling in macrophages
-
批准号:8024493
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2009
-
负责人:Mark Damian Wewers
-
依托单位:
RIP2 caspase-1 signaling in macrophages
-
批准号:7755854
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2009
-
负责人:Mark Damian Wewers
-
依托单位:
RIP2 Caspase-1 Signaling in Macrophages
-
批准号:8402150
-
项目类别:
-
资助金额:$35.34万
-
财政年份:2009
-
负责人:Mark Damian Wewers
-
依托单位:
Macrophage Inflammasome Regulation
-
批准号:6875275
-
项目类别:
-
资助金额:$37.38万
-
财政年份:2004
-
负责人:Mark Damian Wewers
-
依托单位:
Macrophage Inflammasome Regulation
-
批准号:7151145
-
项目类别:
-
资助金额:$35.44万
-
财政年份:2004
-
负责人:Mark Damian Wewers
-
依托单位:
Macrophage inflammasome regulation
-
批准号:8193948
-
项目类别:
-
资助金额:$38.13万
-
财政年份:2004
-
负责人:Mark Damian Wewers
-
依托单位:
Macrophage inflammasome regulation
-
批准号:8282720
-
项目类别:
-
资助金额:$38.13万
-
财政年份:2004
-
负责人:Mark Damian Wewers
-
依托单位:
Macrophage inflammasome regulation
-
批准号:8661216
-
项目类别:
-
资助金额:$37.36万
-
财政年份:2004
-
负责人:Mark Damian Wewers
-
依托单位:
Macrophage inflammasome regulation
-
批准号:9898025
-
项目类别:
-
资助金额:$4.75万
-
财政年份:2004
-
负责人:Mark Damian Wewers
-
依托单位:
Macrophage Inflammasome Regulation
-
批准号:7327773
-
项目类别:
-
资助金额:$35.44万
-
财政年份:2004
-
负责人:Mark Damian Wewers
-
依托单位:
Macrophage inflammasome regulation
-
批准号:8449973
-
项目类别:
-
资助金额:$36.3万
-
财政年份:2004
-
负责人:Mark Damian Wewers
-
依托单位:
Macrophage Inflammasome Regulation
-
批准号:6995190
-
项目类别:
-
资助金额:$36.5万
-
财政年份:2004
-
负责人:Mark Damian Wewers
-
依托单位:
MOLECULAR MECHANISMS OF LUNG INFLAMMATION
-
批准号:6536706
-
项目类别:
-
资助金额:$20.4万
-
财政年份:2000
-
负责人:Mark Damian Wewers
-
依托单位:
Molecular Mechanisms of Lung Inflammation
-
批准号:8029503
-
项目类别:
-
资助金额:$9.38万
-
财政年份:2000
-
负责人:Mark Damian Wewers
-
依托单位:
Molecular Mechanisms of Lung Inflammation
-
批准号:7232975
-
项目类别:
-
资助金额:$23.99万
-
财政年份:2000
-
负责人:Mark Damian Wewers
-
依托单位:
Molecular Mechanisms of Lung Inflammation
-
批准号:8079045
-
项目类别:
-
资助金额:$6.03万
-
财政年份:2000
-
负责人:Mark Damian Wewers
-
依托单位:
Molecular Mechanisms of Lung Inflammation
-
批准号:7595752
-
项目类别:
-
资助金额:$24.19万
-
财政年份:2000
-
负责人:Mark Damian Wewers
-
依托单位:
海外基金